A stabilized CXCL9(74–103)-derived peptide selectively inhibits proliferation, adhesion and metastasis of tumor cells that express high levels of heparan sulfate-Reference-Cited by-同舟云学术

A stabilized CXCL9(74–103)-derived peptide selectively inhibits proliferation, adhesion and metastasis of tumor cells that express high levels of heparan sulfate

Published:2022-12 Issue: Volume:222 Page:2808-2822
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

De Zutter Alexandra,Dillemans Luna,Berghmans Nele,Noppen Sam,Crijns Helena,Verscheure Paulien,Verhaegen Janne,Martens Erik,Vanbrabant Lotte,Pörtner Noëmie,Schols Dominique,Proost Paul,Struyf Sofie

Funder

Vlaamse regering

Fonds Wetenschappelijk Onderzoek

KU Leuven

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference53 articles.

1. The glycocalyx and its significance in human medicine;Tarbell;J. Intern. Med.,2016

2. Endothelial barrier reinforcement relies on flow-regulated glycocalyx, a potential therapeutic target;Harding;Biorheology,2019

3. Mechano-sensing and transduction by endothelial surface glycocalyx: composition, structure, and function;Fu;Wiley Interdiscip. Rev. Syst. Biol. Med.,2013

4. Proteoglycan sequence;Li;Mol. BioSyst.,2012

5. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis;Iozzo;J. Cell. Mol. Med.,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity;Cell Communication and Signaling;2024-02-02

2. CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy;International Journal of Molecular Sciences;2023-10-25

3. PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding;Antiviral Research;2023-09